Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib-Reference-Cited by-同舟云学术

Survival pathway of cholangiocarcinoma via AKT/mTOR signaling to escape RAF/MEK/ERK pathway inhibition by sorafenib

Published:2017-12-13 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Yokoi Kenta¹,Kobayashi Akira¹,Motoyama Hiroaki¹,Kitazawa Masato¹,Shimizu Akira¹,Notake Tsuyoshi¹,Yokoyama Takahide¹,Matsumura Tomio²,Takeoka Michiko¹,Miyagawa Shin-Ichi¹

Affiliation:

1. Department of Surgery, Shinshu University School of Medicine, Matsumoto 390-8621, Japan

2. Department of Molecular Oncology, Shinshu University Graduate School of Medicine, Matsumoto 390-8621, Japan

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining UHPLC-QE-MS mass spectrometry, network pharmacology and molecular docking technology to explore the mechanism of action of TQTMD in the treatment of acute ischemic stroke;2024-09-13

2. Protein regulator of cytokinesis 1 accentuates cholangiocarcinoma progression via mTORC1-mediated glycolysis;Human Cell;2024-02-28

3. Roles of Rictor alterations in gastrointestinal tumors (Review);Oncology Reports;2024-01-04

4. Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma;Frontiers in Pharmacology;2023-09-25

5. Blocking Autophagy by the Two-Pore Channels Antagonist Tetrandrine Improves Sorafenib-Induced Death of Hepatocellular Carcinoma Cells;Toxicology in Vitro;2023-08